Page last updated: 2024-08-21

adamantane and Drug Withdrawal Symptoms

adamantane has been researched along with Drug Withdrawal Symptoms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kolik, LG; Nadorova, AV; Seredenin, SB1
Kolik, LG; Konstantinopolsky, MA1
Bihel, F; Bockel, F; Bourguignon, JJ; Elhabazi, K; Maldonado, R; Meziane, H; Mollereau, C; Moulédous, L; Petit-demoulière, B; Schmitt, M; Simonin, F; Trigo, JM; Zajac, JM1
Gibula-Bruzda, E; Koltunowska, D; Kotlinska, JH; Raoof, H; Silberring, J; Suder, P1
Jung, ME; Simpkins, JW; Wilson, AM1

Other Studies

5 other study(ies) available for adamantane and Drug Withdrawal Symptoms

ArticleYear
Non-Competitive NMDA Receptor Antagonist Hemantane Reduces Ethanol Consumption in Long-Term Alcohol Experienced Rats.
    Bulletin of experimental biology and medicine, 2017, Volume: 164, Issue:2

    Topics: Adamantane; Alcoholism; Animals; Animals, Outbred Strains; Choice Behavior; Disease Models, Animal; Male; Mice; Mice, Inbred DBA; Motivation; Rats; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome

2017
Comparative Assessment of the Effectiveness of Noncompetitive NMDA Receptor Antagonists Amantadine and Hemantane in Morphine Withdrawal Syndrome Model.
    Bulletin of experimental biology and medicine, 2019, Volume: 166, Issue:6

    Topics: Adamantane; Amantadine; Animals; Gene Expression; Hyperalgesia; Injections, Intraperitoneal; Male; Morphine; Morphine Dependence; Motor Activity; Narcotic Antagonists; Rats; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome; Weight Loss

2019
Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.
    British journal of pharmacology, 2012, Volume: 165, Issue:2

    Topics: Adamantane; Analgesics, Opioid; Animals; Behavior, Animal; Conditioning, Classical; Dipeptides; Drug Tolerance; Fentanyl; Hot Temperature; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pain; Receptors, Neuropeptide; Substance Withdrawal Syndrome

2012
Modulation of neuropeptide FF (NPFF) receptors influences the expression of amphetamine-induced conditioned place preference and amphetamine withdrawal anxiety-like behavior in rats.
    Peptides, 2012, Volume: 33, Issue:1

    Topics: Adamantane; Amphetamine; Animals; Anxiety; Behavior, Animal; Conditioning, Psychological; Dipeptides; Dose-Response Relationship, Drug; Male; Maze Learning; Oligopeptides; Rats; Rats, Wistar; Receptors, Neuropeptide; Substance Withdrawal Syndrome

2012
A nonfeminizing estrogen analog protects against ethanol withdrawal toxicity in immortalized hippocampal cells.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 319, Issue:2

    Topics: Adamantane; Animals; Cell Line; Cell Survival; Cytoprotection; Estrogens; Estrone; Ethanol; Hippocampus; Lipid Peroxidation; Malondialdehyde; Protein Carbonylation; Substance Withdrawal Syndrome

2006